Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma
Trial ID or NCT#
NCT00072280
Status
NOT RECRUITING
Purpose
RATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die. Giving combination chemotherapy before surgery may shrink the tumor so that it can be removed. Giving combination chemotherapy after surgery may kill any remaining tumor cells. PURPOSE: This phase II trial is studying how well surgery and/or combination chemotherapy work in treating children with fibrosarcoma.
Official Title
A Pilot Phase II Study for Children With Infantile Fibrosarcoma
Eligibility Criteria
Ages Eligible for Study: Younger than 2 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Exclusion Criteria:
Investigator(s)
Neyssa Marina
Contact us to find out if this trial is right for you.
Contact
Min Wang
6507364281
View on ClinicalTrials.gov
